NEW YORK (GenomeWeb News) – Cancer diagnostics startup On-Q-ity said today that it has closed a $21 million Series A financing round to support the development of a biomarker-based diagnostic for predicting and monitoring cancer treatment effectiveness.

MDV-Mohr Davidow Ventures led the financing round, which also included Bessemer Venture Partners, Physic Ventures, and Northgate Capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.